Acute Myeloid Leukemia - Epidemiology - Europe Data
Diagnosed Incidence of Acute Myeloid Leukemia per 100,000 People of All Ages per Year in 2017 and 2027tttttttttttttttttttttt
Diagnosed Incidence of Acute Promyelocytic Leukemia per 100,000 People of All Ages per Year in 2017 and 2027ttttttttt
Relative Sizes of the Factors Contributing to the Trend in Incident Cases of Acute Myeloid Leukemia over the Next Ten Yearsttttttttt
Relative Sizes of the Factors Contributing to the Trend in Incident Cases of Acute Promyelocytic Leukemia over the Next Ten Yearsttttttttt
Diagnosed Prevalent Cases
Newly Diagnosed Incident Cases
Lifetime DALYs Gained
Studies Included in the Analysis of Acute Myeloid Leukemia
Studies Excluded from the Analysis of Acute Myeloid Leukemia
Risk/Protective Factors for Acute Myeloid Leukemia
Mike Hughes, M.Sc., Ph.D.
Mike Hughes, M.Sc., Ph.D., is the director of the Epidemiology department at DRG, part of Clarivate. He joined DRG in 2006 and has many years’ experience in the mathematical modeling of healthcare service delivery, cardiovascular and cancer epidemiology, biostatistics, meta-analysis, and systematic reviewing. He has been principal author on many published articles in leading international journals in the areas of risk modeling in intensive care and cardiovascular medicine. He also helped develop national guidelines on behalf of NICE and the American College of Chest Physicians for the treatment of atrial fibrillation, stroke, and hypertension. He is particularly interested in modeling patient flows in cancer and methods for forecasting disease burden in noncommunicable epidemiology. Dr. Hughes received his Ph.D. in risk modeling in intensive care in 2003 from City University, London, and his Ph.D. in statistical causation and foundations of probability theory from the University of Nottingham.
Atul Sharma, M.P.H.
Atul Sharma, M.P.H., is an associate epidemiologist at DRG, part of Clarivate. He holds a master’s degree in public health from the School of Public Health, Post-Graduate Institute of Medical Education and Research, and a bachelor’s degree in dental surgery from MN DAV Dental College and Hospital.
Oliver Blandy, M.Sc.
Oliver Blandy, M.Sc., is a senior epidemiologist at Clarivate. Previously, Oliver worked as a research assistant for Imperial College London, where he was the lead for several studies within an NIRH-funded research group investigating healthcare-associated infections and antimicrobial resistance. He holds an M.Sc. from the University of Bristol, where he specialized in nutrition, physical activity, and public health. He also holds a B.Sc. in chemistry and a postgraduate certificate in education, both from the University of Bristol.